Last reviewed · How we verify
Rosuvastatin 20mg
At a glance
| Generic name | Rosuvastatin 20mg |
|---|---|
| Also known as | Crestor 20mg, Crestor, group B, Monorova tablet, ROSU (Crestor®) |
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine (PHASE4)
- PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis (PHASE3)
- Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants (PHASE1)
- [Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers] (PHASE1)
- Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers (PHASE1)
- Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia (PHASE3)
- Effects of Short-term Intensive Statin Therapy on Lipid Levels
- Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |